Neoplasms

Symptoms and General Pathology

All Conditions

Digestive System Diseases

Neoplasm Metastasis

Hemorrhage

Neoplasms, Second Primary

Liver Neoplasms

Neoplastic Processes

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Hematinics

All Drugs and Chemicals

Liver Extracts

Pre-coagulation of the liver parenchyma with HIFU and standard liver resection

6 to 10 (or more if necessary) side-to-side 40-seconde HIFU treatments

Pre-coagulation of the liver parenchyma with HIFU

Michel RIVOIRE, MD, PhD

The purpose of this study is to evaluate whether HIFU-assisted liver resection (HIFU-AR) results in reduced blood loss compared to standard liver resection in patients with LM.This is a prospective, monocentric, randomized (1:1 ratio), comparative, open-label Phase II study.

Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy

Randomized, Open-label, Phase II Study to Evaluate the Efficacy of High-Intensity Focused Ultrasound Assisted Hepatic Resection (HIFU-AR) on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy

To compare the blood loss during hepactectomy in patients treated by HIFU-AR versus standard liver resection

Centre Leon Berard

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy	NCT02728167	Liver Metastasi...	Pre-coagulation...	18 Years -	Centre Leon Berard
Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy	NCT02728167	Liver Metastasi...	Pre-coagulation...	18 Years -	Centre Leon Berard

Spots Global Cancer Trial Database for liver metastases (lm) requiring surgery